FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection
H. Baazim, E. Koyuncu, G. Tuncman, M. F. Burak, L. Merkel, N. Bahour, E. S. Karabulut, G. Y. Lee, A. Hanifehnezhad, Z. F. Karagoz, K. Foldes, I. Engin, A. G. Erman, S. Oztop, N. Filazi, , G. S. Hotamisligil
This study identifies FABP4 as a host target that modulates SARS-CoV-2 infection, showing that its inhibition reduces viral replication and lung damage in infected hamsters.
bioRxiv · Feb 10, 2024 · PreprintMicrobiology